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THE ROLE OF α3β4* SUBTYPE OF NICOTINIC ACETYLCHOLINE 
RECEPTORS IN REVERSING OPIOID-INDUCED CONSTIPATION IN MICE 
By Aravind Reddy Gade, MS 
A Dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2015 
 
Major Director:  Hamid I. Akbarali, Ph.D. 
Professor, Department of Pharmacology and Toxicology 
Opioids are excellent pain relievers. A major side-effect of chronic opioid 
treatment is constipation whereas withdrawal following chronic exposure leads to 
diarrhea and increased gastrointestinal motility. These effects of chronic opioids 
are mediated by µ-opioid receptors expressed on enteric neurons. Previous 
studies have shown that chronic opioids enhance sensitivity to nicotine in the 
gastrointestinal tract. This suggested that prokinetic effects of nicotine mediated 
through the activation of nicotinic acetylcholine receptors (nAChRs) may be 
useful in reversing opioid-induced constipation. The goal of this dissertation was 
to investigate the nAChR subtype expressed on enteric neurons and their role in 
reversing opioid-induced constipation. The effect of nicotine on small intestinal 
transit and fecal pellet output were determined in-vivo in morphine-pelleted mice 
xiii 
 
(75 mg for 4 days).  Nicotine-induced currents were measured by whole-cell 
voltage clamp in isolated adult mouse myenteric neurons treated with morphine 
over short term (10 mins) and long term (16-20 hrs). Following long term 
morphine exposure in-vivo (morphine pellet – 4 days), nicotine increased fecal 
pellet output, and enhanced small intestinal transit.  The prokinetic effect of 
nicotine was not seen in placebo pelleted mice or after acute morphine (10 
mg/kg, 30 min).  Peak-amplitude of nicotine-induced inward currents in isolated 
neurons was also enhanced after long-term but not short term exposure to 
morphine.  Nicotine-induced currents were inhibited by mecamylamine (10 µM) 
and α-conotoxin AUIB (3 µM), suggesting the expression of α3β4 subtype of 
nAChRs on enteric neurons. Conversely, NS3861, a partial agonist at α3β4 
nAChR enhanced fecal pellet expulsion in a dose-dependent manner in chronic 
but not acute morphine treated mice. Overall, our findings suggest that the 
efficacy of nAChR agonists on enteric neurons is enhanced after chronic 
morphine exposure and activation of α3β4 subtype of nAChR reverses chronic 
but not acute morphine induced constipation.  In conclusion, development of 
peripherally selective α3β4 partial agonists may be of therapeutic benefit in 
treatment of chronic opioid-induced constipation. 
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CHAPTER I 
INTRODUCTION 
Opiate alkaloids derived from the plant Papaver somniferum have been used to 
treat pain for over thousand years. They are the most commonly prescribed 
drugs to treat chronic nonmalignant pain in the US (Nelson et al., 2015). In spite 
of their highly efficacious analgesic properties, side effects such as tolerance, 
addiction and gastrointestinal adverse effects limit their clinical utility. 
Gastrointestinal adverse effects include nausea and vomiting, abdominal pain 
and constipation which are collectively referred to as opioid-induced bowel 
dysfunction (OBD) (Panchal et al., 2007). Apart from OBD, opioid use during 
surgeries frequently results in post-operative ileus, a condition where the small 
intestine is temporarily paralyzed (Lubawski et al., 2008).  
In spite of the discomforting side effects, the number of opioid prescriptions is on 
the rise in the US. The dispensing of opioid analgesics increased from 149 
million prescriptions in the year 2003 to 203 million prescriptions in the year 2013 
and over 4% of US adults are taking opioids, primarily for noncancer pain 
(Nelson et al., 2015). The increase in opioid use is encountered with an increase 
in opioid induced constipation (OIC) cases in the gastroenterology clinics. 41-81 
% of the patients on chronic opioids with noncancer pain report problems of OIC 
(Holzer, 2008). Figure 1 illustrates the increase in opioid usage and opioid 
treatment admissions during the years 1999-2010 
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Conventional treatment strategies for constipation such as use of laxatives, stool 
softeners and dietary fiber are effective in less than 50 % of OIC cases and are 
associated with adverse side effects (Nelson et al., 2015). Alternate approaches 
for the treatment of OIC include targeting the site of action of opioids in the 
periphery without altering its CNS effects. 
 
Figure 1: Rates of opioid sales and opioid abuse treatment admissions during 
the years 1999-2010. Reproduced from: 
Ref:http://www.cdc.gov/HomeandRecreationalSafety/pdf/HHS_Prescription_Drug
_Abuse_Report_09.2013.pdf 
The analgesic effects of opioids are mediated through the µ-opioid receptors 
(MOR) in the CNS whereas side effects such as constipation are mediated 
primarily through the µ-opioid receptors expressed in the periphery. In the 
periphery, µ-opioid receptors are highly expressed in the GI tract, primarily on the 
enteric neurons. Opioids decrease the firing of enteric neurons, which leads to 
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decrease in propulsion and secretion in the GI tract ultimately leading to 
constipation (Wood et al., 2004).  
Peripherally active µ-opioid receptor antagonists (PAMORAs) can reverse the 
opioid effects in the periphery without altering the analgesic properties. 
PAMORAs such as methylnaltrexone, alvimopan and nalaxogel induce bowel 
movements in both OIC and post-operative ileus cases and improves the quality 
of life of patients on opioids (Holzer, 2008; Nelson et al., 2015). In spite of 
inducing effective treatment for OIC, long term use of PAMORAs is associated 
with cardiovascular side effects (McNicol et al., 2008). 
Apart from antagonizing opioid receptors, activating other receptor types also 
help in treating OIC. Activating the 5HT4 receptors of enterochromaffin cells and 
ClC-2 channels of intestinal apical epithelial membrane produce prokinetic 
effects. Lubiprostone, a ClC-2 channel activator, recently received US Food and 
Drug Administration (FDA) approval for OIC in noncancer patients. Prucalopride, 
an agonist at 5HT4 receptor, is currently under clinical trials for OIC (Nelson et 
al., 2015). 
Notwithstanding the prokinetic effects of these drugs, our understanding of the 
process (es) leading to opioid-induced constipation is still rudimentary. While 
tolerance develops to many of the effects of opioids following chronic use, opioid-
induced constipation does not become tolerant (Galligan et al., 2014).  This is 
largely due to the lack of tolerance development in the colon. One hypothesis is 
that chronic opioid does not reduce β-arrestin2 levels in the colonic neurons 
resulting in maintained opioid-induced signaling (Kang et al., 2012; Ross et al., 
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2008). It is therefore desirable to define targets that can enhance neuronal 
activity following long-term opioid exposure. The work described in this thesis 
relates to early findings that chronic morphine induces supersenstivity to nicotine 
in enteric neurons (Goldstein et al., 1973; Johnson et al., 1978). Since nicotine 
stimulates gastrointestinal motility, the focus of this study is to determine the 
mechanism and potential use of nicotinic receptor ligands in opioid-induced 
constipation. 
Nicotinic Acetylcholine receptors (nAChR) are widely expressed in the GI tract, 
primarily on the enteric neurons (Zhou et al., 2002). Compounds targeting 
nAChRs are currently in clinical trials for treating GI disorders such as diabetic 
gastroparesis and irritable bowel syndrome (IBS). 
(https://www.clinicaltrials.gov/ct2/show/study/NCT01149200). 
In the following background section, I provide an overview of the gastrointestinal 
tract, the role of nicotinic receptors and opioid-induced constipation. 
BACKGROUND: 
A. Enteric nervous system and GI Motility: 
The function of gastrointestinal (GI) tract is governed by central nervous system 
(CNS) and autonomic nervous system (ANS). ANS includes sympathetic, 
parasympathetic and enteric nervous system (ENS). The contribution of CNS 
and ANS differ considerably along the GI tract. The striated muscles of the upper 
esophagus are innervated directly by the neurons with cell bodies in the medulla 
oblongata and the smooth muscles of the lower esophagus are innervated by the 
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enteric neurons of the ENS. In spite of the presence of intrinsic connections, the 
peristalsis in the esophagus is primarily controlled by the neuronal connections 
from the CNS. Severing the central connections leads to the complete paralysis 
of esophagus suggesting a major role played by the CNS. Similarly in the 
stomach, contractile activity and acid secretion are primarily governed by the 
CNS through vago-vagal reflexes. However removal of the central connections 
does not paralyze the stomach suggesting a partial role played by the ENS. In 
the lower GI tract (small and large intestine), ENS plays an important role in 
regulating the GI motility, secretion and absorption. Although, CNS has 
significant innervations in the lower GI tract, severing these connections do not 
alter the peristaltic movements in the gut. In the lower GI, CNS’s control is 
pronounced primarily near the rectal region where it regulates the voluntary 
control of defecation. In contrast to CNS, altering the ENS structure or function in 
the lower GI tract is fatal (Brookes et al., 2013; Furness, 2012; Furness, 2008; 
Lomax et al., 2010).  
The enteric nervous system is composed of two plexii, myenteric and 
submucosal plexus. While myenteric plexus regulates the motility patterns in the 
GI tract, mucosal plexus regulate the absorption and secretory functions. The 
ganglia within each plexus are composed of cell bodies of sensory, motor and 
interneurons. Based on the type of neurotransmitter released they are classified 
as excitatory or inhibitory. There are around 30 different neurotransmitters 
involved in the neurotransmission in the ENS. Acetylcholine and ATP are the 
major excitatory neurotransmitters whereas NO and VIP contribute to the 
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majority of inhibitory neurotransmission in the GI tract (Furness, 2012; Grider, 
2003). Figure 2 and 3 illustrate the basic organization and localization of enteric 
nervous system in the GI tract. 
The enteric  nervous system’s role in initiation and propagation of peristalsis in 
the intestine was first identified by Bayliss and Starling in the small intestine of 
dog at the end of 19th century (Bayliss et al., 1899). Peristalsis in the wall of 
intestine is initiated by the stretch receptors expressed on the enterochromaffin 
cells lining the lumen of intestine. Upon activation of stretch receptors by the 
luminal contents, enterochromaffin cells release serotonin, which further 
activates the nerve endings of sensory neurons. Sensory neurons communicate 
with the neurons in the myenteric ganglia and activate the excitatory motor 
neurons towards oral side to cause a contraction and inhibitory motor neurons 
towards anal side to cause a relaxation. The alternate contraction and relaxation 
in the intestine initiates a peristaltic movement. These movements progress 
along the wall of intestine by the means of signals sent through interneurons and 
help in the movement of luminal contents (Bornstein et al., 2004; Grider, 2003; 
Kunze et al., 1999).  
The structure and function of ENS is altered in disease states and by different 
drugs. In enteric neuropathies such as Hirschsprung’s disease, where parts of GI 
tract have no enteric ganglion cells, the smooth muscle cannot relax and pass 
the stool. This causes bowel obstruction and leads to complications such as 
megacolon (De Giorgio et al., 2004). In majority of cases, treatment involves the 
removal of effected part to prevent death. Similar symptoms are also seen in 
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Chagas disease, an enteric neuropathy caused due to the infection with 
protozoan Typanosoma Cruzi (da Silveira et al., 2007).  
A number of drugs used clinically alter the GI motility through their actions on the 
enteric neurons. Motilin and erythromycin stimulate the GI motility, in part by 
activating the cholinergic neurons. Local application of Botulinum toxin reduces 
the GI motility by inhibiting the release of acetylcholine from the cholinergic 
neurons. Opioids analgesics induce side effects such as constipation by 
activating the µ-opioid receptors expressed on enteric neurons. Loperamide, a 
partial agonist at µ-opioid receptor produces its anti-diarhheal effects through a 
similar mechanism (Tack, 2000). 
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Figure 2: Organization of enteric nervous system in the GI tract. Myenteric 
plexi are present in between the longitudinal and circular muscle layers whereas 
the submucosal plexi are localized in the submucosal layer.  
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B. Morphine and GI motility: 
Morphine, an opioid analgesic has been used for the treatment of pain for over 
thousand years. In spite of being a potent analgesic, side effects such as 
constipation limit its clinical utility. Reports of morphine induced constipation in 
the literature date back to 1800’s. However the mechanism involved was not 
understood until 1950’s, when Paton identified morphine induced suppression of 
acetylcholine release in an isolated guinea pig ileum preparation (Paton, 1957).  
Paton examined the electric field stimulated (EFS) contractions of isolated guinea 
pig ileum in an organ bath setup. In these experiments, exposure to morphine 
suppressed the EFS stimulated contractions in the longitudinal muscle of guinea 
pig ileum (Paton, 1957). In a longitudinal muscle preparation containing the 
myenteric plexus and longitudinal smooth muscle, EFS stimulates the release of 
acetylcholine at the neuromuscular junction to induce contractions. Exposure to 
morphine inhibits the release of acetylcholine resulting in a depression in the 
EFS induced contractions. In a circular muscle preparation, there is a continuous 
ongoing release of inhibitory neurotransmitters (VIP and NO) by the inhibitory 
neurons to maintain the tone of muscle. Application of morphine in such a 
preparation induces contractions by suppressing the release of inhibitory 
neurotransmitter (Grider et al., 1987; Wood et al., 2004).  
Application of morphine in vivo and in vitro are frequently encountered with 
decrease in contractile activity and increase in segmental contractions in the 
intestinal segments leading to suppression of peristaltic propulsion and increase 
in intraluminal pressure. The decrease in contractile activity is best explained 
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with the decrease in the acetylcholine release at the neuromuscular junction of 
longitudinal muscle. Unlike longitudinal muscle, the circular muscle is primarily 
innervated by the inhibitory neurons and a decrease in the release of inhibitory 
neurotransmitter release by morphine is therefore expected to induce segmental 
contractions (Ross et al., 2008) (Grider et al., 1987). 
Morphine’s actions in the intestine are mediated through the activation of µ-opioid 
receptors expressed on the enteric neurons. Electrophysiological recordings 
reveal that morphine acts by hyperpolarizing the membrane potential of enteric 
neurons through the activation of K+ channels and inhibition of Na+ and Ca2+ 
channels (Akbarali et al., 2014; Smith et al., 2012; Wood et al., 2004). While the 
hyperpolarization of the myenteric neurons suppresses the neurotransmitter 
release at the neuromuscular junction, hyperpolarization of submucosal neuron 
suppresses the secretion in the intestine. Suppression of secretion along with 
propulsion ultimately leads to constipation and hard stools.  
The effects of morphine are not the same after chronic exposure. Chronic 
exposure to morphine develops tolerance and dependence in the CNS. Similarly 
in the GI tract, chronic morphine develops tolerance and dependence to the 
contractile effects in the ileum but not colon. Previous work done by Ross et al 
demonstrated that, in a circular muscle preparation, morphine induced 
contractions are depressed after repeated exposures in the ileum but not colon 
(Ross et al., 2008). This difference is attributed to the differential downregulation 
of β-arrestin2 in the ileum and colon following morphine exposure. β-arrestin 2 
levels in the ileum are decreased following chronic morphine exposure. However 
12 
 
the levels of β-arrestin2 are not altered in the colon. Moreover, in a β-arrestin 2 
knock out animal, tolerance to morphine develops in both ileum and colon (Kang 
et al., 2012). This implies the important role played by β-arrestin 2 in morphine 
tolerance. 
Enhanced contractility in the GI tract, leading to symptoms such as diarrhea is 
seen in patients during morphine withdrawal. Similar symptoms are also 
witnessed in animals induced with precipitated withdrawal by injecting naloxone 
after prolonged exposure to morphine. The gastrointestinal phenotype of 
morphine dependent animals is attributed to the modification of the intracellular 
environment of the enteric neurons leading to enhanced phosphorylation of 
adenylate cyclase (Chakrabarti et al., 1998), alterations in cholinergic signaling 
(Neugebauer et al., 2013), enhanced sensitivity to neuronal agonists (Goldstein 
et al., 1973; Johnson et al., 1978) etc. Targeting these altered signaling 
mechanisms may help in reversing the withdrawal symptoms. For example, 
targeting the cholinergic signaling by using nicotinic antagonists are known to 
decrease morphine withdrawal symptoms.  
C. nAChRs and GI motility: 
Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand gated ion 
channels expressed primarily in the nervous system. They are highly expressed 
in the GI tract, primarily on the enteric neurons and contribute to the excitatory 
neurotransmission. They are cation channels and are permeable to Na+ and 
Ca2+. When activated at resting membrane potential, they allow the flow of ions 
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across the membrane to depolarize the cell. nAChRs play an important role in 
regulating the inflammation and motility in the GI tract (Wu et al., 2004). 
Nicotine, an agonist at the nAChRs alters different functions of the GI tract in 
normal and disease conditions. Nicotine has both pro and anti-inflammatory 
effects in the GI tract (Wu et al., 2004). α7 nAChR containing immune cells are 
expressed in the GI tract and mediate the anti-inflammatory effects of nicotine. 
Nicotine acts as an anti-inflammatory agent in the treatment of ulcerative colitis 
and smokers are reportedly at a lower risk to develop ulcerative colitis (UC) 
(AlSharari et al., 2013) (Wu et al., 2004). However, it also has pro-inflammatory 
effects in diseases such as Crohn’s where it worsens the symptoms (Thomas et 
al., 2000). This difference in the actions of nicotine is attributed to the different 
types of immune cells involved in Crohn’s and UC (Thomas et al., 2000). Nicotine 
also protects the gut barrier during burn injuries by acting at the α7 nAChRs 
expressed on the epithelial cells (Costantini et al., 2012).    
nAChR receptor family in the mammalian nervous system consists of 11 
subunits: α2 - α9 and β2 – β4 and the subunit composition can be homomeric or 
heteromeric (McGehee, 1999; Sargent, 1993). The pharmacological and 
electrophysiological properties are unique for each subunit combination. 
Pharmacological and immunohistochemistry studies of nAChR subunits in the 
enteric neurons of neonatal guinea pig have shown the functional expression of 
α3, α5, β2, β4 subunits (Zhou et al., 2002). However, the specific role of each of 
these subunits in nAChR mediated responses in the GI tract is not clear. Figure 4 
shows the structure and organization of nAChRs in the membrane. 
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nAChRs are expressed on the sensory, inter and motor neurons of the myenteric 
ganglia in the ENS and targeting them alters the motility significantly. Local 
administration of monoclonal antibodies against α3 subunit decreases the motility 
in the small intestine of mice suggesting the importance of nAChRs of GI tract in 
regulating the GI motility (Meeusen et al., 2013). Moreover autoantibodies 
against α3 nAChR have been shown to cause autoimmune motility disorder such 
as autoimmune gastrointestinal dysmotility (AGID) (Lennon et al., 2003). Nicotine 
induces contractions in the isolated ileum tissue by activating the nAChRs 
expressed on enteric neurons of the myenteric ganglia (Fishlock et al., 1966).  It 
stimulates the GI tract to increase the gastric emptying in smokers (Grimes et al., 
1978). Similarly, local application of nicotine patches accelerates motility in the 
large intestine and decreases the total colonic transit time (Rausch et al., 1998).  
Although nicotinic receptors are potential targets for accelerating motility, 
targeting them for the treatment of motility disorders has gained importance only 
recently. Compounds targeting the nAChRs are currently under clinical trials to 
increase GI motility in patients suffering with diabetic gastroparesis and irritable 
bowel syndrome (https://www.clinicaltrials.gov/ct2/show/study/NCT01149200).  
nAChRs may serve as targets for treating motility disorders especially opioid 
induced constipation as the sensitivity of nAChRs agonists in the intestine is 
enhanced after prolonged exposure to morphine (Johnson et al., 1978). The 
changes in cholinergic signaling mediated through nAChRs play an important 
role in morphine withdrawal and therefore are potential targets to treat morphine 
withdrawal symptoms (Neugebauer et al., 2013). For example, α3β4* nAChR 
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antagonists can decrease the central and peripheral symptoms seen during 
morphine withdrawal (Muldoon et al., 2014). Therefore it of interest to examine 
the alterations in the activity and expression of these receptors after morphine 
exposure which may provide an insight into the mechanism of action involved in 
morphine withdrawal symptoms.  
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Figure 4: Structure and organization of nicotinic acetylcholine receptors A) 
Nicotinic receptors are comprised of five subunits B) The subunits of nAChR may 
be homomeric or heteromeric C) Each subunit is made up of four 
transmembrane domains D) Model structure of α7 containing nAChR from 
(http://www.niehs.nih.gov/research/atniehs/labs/ln/icp/index.cfm). 
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CHAPTER II 
MATERIALS AND METHODS: 
Materials: Sodium Chloride (NaCl), magnesium chloride (MgCl2), calcium 
chloride (CaCl2), glucose, ATP disodium salt, HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), EGTA(ethylene glycol tetraacetic acid), Nicotine 
hydrogen tartarate, mecamylamine and hexamethonium were purchased from 
Sigma-Aldrich (St. Louis, MO).  Potassium chloride (KCl) was purchased from 
Fisher Scientific (Waltham, MA) and collagenase was purchased from 
Worthington (Lakewood, NJ). Laminin and Poly D-Lysine were purchased from 
BD bioscience (Franklin lanes, NJ), GDNF (glial cell-derived neurotrophic factor) 
was purchased from Neuromics (Edina, MN), FBS (fetal bovine serum) was 
purchased from Gemini Bio products (West sacremento, CA), B-27, Trypsin and 
neurobasal A media were purchased from Thermofisher (Waltham, MA). 
NS3861(Harpsoe et al., 2013), α – conotoxin MII(Harvey et al., 1997) and α – 
conotoxin AUIB (Luo et al., 1998) were purchased from Tocris Bioscience 
(Bristol, UK).  Morphine sulphate and morphine pellets (75 mg) were obtained 
from National Institutes of Drug Abuse (Bethesda, MD).  
Animals: Adult male Swiss-Webster mice (25-30g) (Harlan Laboratories) housed 
in 12/12 light/dark cycle vivarium were used for the experiments. Mice expressing 
Tdtomato in cholinergic neurons were developed by crossing B6;129S6-
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (Jax stock no. 007905) X B6;129S6-
Chattm2(cre)Lowl/J (Jax stock no. 006410). Similarly, mice expressing tdtomato in 
VIP neurons were developed by crossing STOCK Viptm1(cre)Zjh/J (Jax stock no. 
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010908) X B6;129S6-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (Jax stock no. 007905). 
Mice null for the α5 and α7 (Jackson Laboratories), α6 and β2 (Institut Pasteur, 
Paris, France) nAChR subunits and their wild-type (WT) littermates were bred in 
an animal care facility at Virginia Commonwealth University (Richmond, VA).  
These mice were backcrossed at least 12 to 15 generations to C57BL/6J mice 
(Jackson Laboratories).  Mutant/transgenic and WT littermates were obtained 
from crossing heterozygous mice. All the protocols were approved by Virginia 
Commonwealth University institutional animal care and use committee. Morphine 
or nicotine were administrated in mice through intraperitoneal (i.p.) route. 
Animals were exposed to morphine long term through surgical implantation of 75 
mg morphine pellet for four days. 
Surgical Implantation of Pellets: Pellets were implanted as previously 
described (Ross et al., 2008). Mice were anesthetized with 2.5 % isoflurane and 
the hair on the back of their neck was shaved. Lack of response to a pinch on the 
toe and absence of righting reflex were used as signs to assess adequate 
anesthesia. Sterile surgical equipment was used for the process to minimize any 
potential contamination. Shaven skin was cleaned with povidone iodine (General 
Medical Corp., Prichard, WV) and rinsed with alcohol. A 1 cm horizontal incision 
was made at the base of the skull and the underlying subcutaneous space was 
moved towards the dorsal flanks using a glass rod. A placebo or morphine pellet 
was inserted in this space and closed using a 9 mm wound clips (BD bioscience, 
San Jose, CA). Iodine was applied again after closing the site and the animals 
were allowed to recover in their home cages. 
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Enteric Neuron Cell Isolation: Enteric neurons were isolated as previously 
described (Smith et al., 2013) (Smith et al., 2012). Ileum tissue was obtained 
immediately from a euthanized mice and placed in ice cold Krebs solution (in 
mM: 118 NaCl, 4.6 KCl, 1.3 NaH2PO4, 1.2 MgSO4 25, NaHCO3, 11 glucose and 
2.5 CaCl2) and bubbled with carbogen (95% O2/5% CO2)). The luminal contents 
were flushed with ice-cold Krebs and the tissues threaded on a plastic rod 
through the lumen.  The longitudinal muscle layer with the adherent myenteric 
plexus was gently stripped using a cotton-tip applicator. Isolated longitudinal-
myenteric plexus (LMMP) was then minced and subjected to digestion with 
collagenase for one hour at 37oC in the water bath. After digestion the tissue was 
collected using centrifugation and subjected to treatment with trypsin for 7 mins 
at 37oC in the water bath. After digestion the tissue was mixed with DMEM media 
containing FBS and antibiotics to neutralize trypsin. Tissue was then collected 
and washed in the neurobasal media. The washed tissue is passed through a 70 
µm sieve to remove any undissipated tissue. The isolated cells were collected 
through centrifugation and plated on laminin and poly d-lysine coated cover slips 
in neurobasal A media containing 1% FBS, 1X B-27 and 10 ng/ml glial cell 
derived neurotropic factor (GDNF) and penicillin/streptomycin.  
Electrical Recordings: Standard whole cell configuration was used for all the 
recordings. EPC 10 amplifier (HEKA, Bellmore, NY) was used for recordings. 
Enteric neurons from Days 1 and 2 after isolation were used for all the patch 
clamp experiments. Cells were placed in a perfusion chamber and continuously 
perfused with external solution containing (in mM) 135 NaCl, 5.4 KCl, 0.3 
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NaH2PO4, 1 MgCl2 , 5 glucose and 2 CaCl2 (PH adjusted to 7.4 using 1M 
NaOH). The micro pipettes (Patch electrodes) were prepared using Flaming-
Brown horizontal puller (P-87; Sutter Instruments, Novato, CA) and fire polished. 
Resistance of the pipettes used was 1.5-2.5 MΩ. Pipettes were filled with internal 
solution containing in mM 100 K-aspartic acid, 30 KCl, 4.5 ATP, 1 MgCl2, 10 
HEPES, and 0.1 EGTA. Series resistance was less than 10 MΩ and not 
compensated. The voltage clamp recordings were performed at a holding 
potential of -60 mv. The currents were measured by either giving a series of 
voltage pulses or recorded using a gap free protocol at -60 mV. Action potentials 
were induced in the neurons by giving a series of current injections to the cell in a 
current clamp mode at resting membrane potential. Nicotine and ATP were 
perfused into the bath solution. The cells were washed after each nicotine 
exposure for at least 3 mins before exposing it to the next concentration.  
PCR: Quantitative real time PCR was performed on RNA extracted from the 
ileum LMMP. LMMP tissue was first collected in trizol and RNA was extracted 
using the manufacturer’s protocol (Life technologies, Cat # 15596, Carlsbad, 
CA). PCR experiment was performed following the BIO-RAD (Hercules, CA) iTaq 
Universal SYBR Green One-Step Kit. In order to quantify the mRNA of nAChRs, 
a standard curve was first plotted using different concentrations of genomic DNA 
with each primer. The standard curve is plotted based on the ct value obtained at 
each concentration of DNA. The quantity of mRNA in the LMMP sample was 
determined based on the position of ct value of the sample in the standard curve. 
Copy number was calculated using the online tool available at 
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scienceprimer.com.  Experiments were performed in triplicates from five separate 
biological samples. 18s rRNA was used as internal control to quantify the 
normalized fold change. Primers used are listed in table 1. 
Gene               Forward Primer Reverse Primer 
α3        5'-
CCGCTGTCCATGCTGATGCT-
3' 
      5'-
GCCACAGGTTGGTTTCCATG-3' 
α4        5'-
TGCCGCTCCTGCTGCTCTTA-
3' 
      5'-
GCGGACAAGGACCACATCTG-3' 
α5        5'-
GTTGCCTGAGCTATCCTCTG-
3' 
        5'-
GTTGCCTGAGCTATCCTCTG-3' 
α6        5'-
GACCAGGGAAACCTGCACTC-
3' 
      5'-
GATCGGAGACATTCTCCACC-3' 
β2        5'-
TGCTCCAACTCTATGGCGCT-
3' 
      5'-
CACCAGCTCAGAGCCATTAG-3' 
β3        5'-
CAGGCTTCCTACGGGTCTTC-
3' 
      5'-
GGGCGGACACATTTCTGATA-3' 
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β4        5'-
CCCTGCTCCTCGTCTCTCTGT
T-3' 
      5'-
TGGAGATGAGCTGGGAGGAG-3' 
 
Table 1: Primers used for the PCR experiments. All the primers are designed 
using vector NTI®. 
Upper gastrointestinal motility by charcoal meal test: Mice were divided into 
the following groups for the experiment. 1) Control (Placebo-pelleted (4-days)) 2) 
Acute morphine –treated (Placebo-pelleted + single 10 mg/kg morphine injection) 
and 3) chronic morphine (75 mg morphine-pelleted (4-days)). Animals were 
fasted overnight with access only to water and were placed on an elevated mesh 
to prevent the ingestion of their own feces. On the day of experiment, animals 
were given charcoal through an oral gavage and were sacrificed thirty mins later 
and the small intestine was removed and placed on ice. Charcoal was 
administered immediately after an i.p. injection of saline or nicotine. Charcoal 
transit was assessed based on the localization of the leading edge of charcoal in 
the intestine. Small intestinal transit is calculated as a function of whole small 
intestine length from the pylorus. The following formula was used to calculate 
small intestinal transit = (Charcoal transit) / (Total length of the small intestine 
from pylorus to caecum) X 100.   
Total fecal pellet output:  Fecal pellets were measured as an indication of the 
total gastrointestinal motility.  These studies were conducted in a blinded fashion 
with pellet counting done by an observer oblivious to the group being tested.  
23 
 
Mice were divided into the following groups. 1) Control (Placebo-pelleted (4-
days)) 2) Acute or short term morphine –treated (Placebo-pelleted + single 10 
mg/kg morphine injection) and 3) chronic or long term morphine (75 mg 
morphine-pelleted (4-days)). The nicotine doses were chosen based on the 
results from small intestine transit assay. Mice in each group were injected with 
saline or 0.5, 1.0, 1.5 and 3 mg/kg nicotine (i.p.) and placed in an empty cage. 
The number of fecal pellets expelled between thirty and sixty mins after the 
injection were counted. Acute morphine injections were given twenty mins prior 
to the saline or nicotine injections.  A similar separate group of mice were tested 
for the effects of NS3681 (0.01, 0.05, 0.1 and 0.5 mg/kg i.p.). All the nicotine 
doses are calculated by multiplying the dose of salt with 0.35 (Base/Anhydrous 
salt) as described earlier (Matta et al., 2007). 
Data Analysis: Sigma Plot 11.0 and GraphPadPrism6 were used for data 
analysis. All the data were represented in mean ± SEM and scattered plots were 
used to show the distribution. P value less than 0.05 was considered significant. 
T-test was used to compare the differences between two different groups. Dose-
response to nicotine in charcoal meal test and fecal pellet output assay were 
analyzed using One-Way ANOVA and fisher’s LSD. Dose-response to NS3861 in 
fecal pellet out assay was analyzed using One-Way ANOVA and tukey kramer 
post-hoc test. Dose-response to nicotine in patch clamp experiments were 
analyzed using Two-Way ANOVA and tukey kramer post hoc test. Tests are also 
mentioned under figure legends. EC50 values were calculated using lease 
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square linear regression analysis followed by calculation of confidence limits 
(Bliss, 1967). 
Longitudinal Muscle Myenteric Plexus (LMMP) preparation and 
Immunohistochemistry: Mice were euthanized and the segments of ileum are 
placed in a dissecting dish containing ice cold PBS. The contents of the intestine 
were flushed using PBS and the tissue was cut open across the myenteric border 
using a fine scissors. The sheet of tissue was pinned and stretched on a 
dissecting plate containing Sylgard. Tissue was then fixed with 4% 
paraformaldehyde for 4 hrs. After exposure to formaldehyde, tissue was washed 
three times with 1X PBS and placed under the microscope to strip of the layers of 
intestine. Using a fine forceps, mucosa, submucosa and circular muscle layers 
are stripped off and the longitudinal muscle layer is exposed. The isolated LMMP 
preparation was used for immunostaining or stored in 0.1% sodium azide for 
future use. Before the immunostaining, tissue was permeabilized with 0.5 % 
triton x-100 for 1 hr and blocked with 10% normal goat serum for 1 hour. Tissue 
was then treated with desired primary (Overnight) and secondary antibodies (4 
hours) for immunostaining. After the treatment with antibodies, the tissue was 
transferred onto a glass slide and allowed to dry. A drop of mounting media was 
placed on the dried tissue and covered off with a cover glass. The cover glass is 
then sealed off using glue at the corners before visualizing under the microscope. 
Immunocytochemistry: Enteric neurons isolated from the mouse ileum and 
maintained in culture for 4 days were used for immunostaining. Cells were fixed 
by exposure to 4% paraformaldehyde for half-hour, permeabilized with 0.5 % 
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triton x-100 for half hour and blocked with 10% normal goat serum for 1 hour. 
Cells were then treated with desired primary (Overnight) and secondary 
antibodies (1 hour) for immunostaining. Cells were washed three times with 1X 
PBS between each step. The antibodies used for immunostaining are listed in 
table 2. 
 
    Antibody (Host)             Source                        Concentration 
Primary antibodies                                                                                           
 β-III tubulin (rabbit)             Abcam                               1:100 
GFAP (mouse)                       Chemicon                             1:500 
Calretinin (goat)                          Swant                                   1:100 
Calbindin (mouse)             Swant                                1:100 
NOS1 (mouse)                           Santa Cruz               1:50 
MOR (Rabbit)                          Alamone Labs               1:500 
Secondary antibodies                                                                                      
Alexa 488 - Conjugate             Life Technologies               1:1000 
Alexa 594 - Conjugate             Life Technologies               1:1000 
 
Table 2: Antibodies used for the immunostaining experiments. 
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CHAPTER III 
Effects of morphine on nAChR activity in isolated enteric neurons: 
As mentioned earlier, the sensitivities to nicotine and other neuronal agonists are 
enhanced in the isolated ileum of morphine tolerant guinea pigs (Goldstein et al., 
1973; Johnson et al., 1978). The changes in the sensitivities are due to the 
changes in the cellular functions in the enteric neurons of myenteric ganglia. 
Fleming et al correlated the super sensitivity of neuronal agonists to the changes 
in the resting membrane potential of the enteric neurons (Fleming et al., 1988). 
Microelectrode recordings on the longitudinal muscle myenteric plexus from an 
isolated ileum of morphine tolerant guinea pig displayed depolarization of enteric 
neurons (Leedham et al., 1992). These changes were attributed to the alterations 
in the activity of sodium-potassium pump expressed on the enteric neurons 
(Kong et al., 1997). However, the effects of morphine on the activity of neuronal 
receptors are not well understood.  
Synaptic transmission in the enteric nervous system is mediated through the G-
protein coupled receptors (GPCRs) and ligand gated ion channels. GPCRs 
mediate the neurotransmission through a slow multi step process that includes 
the binding of ligand to the receptor followed by activation of intracellular 
signaling leading to alteration of ion channel function. They primarily mediate the 
slow excitatory and inhibitory postsynaptic potentials in the enteric nervous 
system. In the case of ligand gated ion channels, ligand binds directly on the 
channel complex leading to the alteration of channel activity ultimately leading to 
the transmission of signal. This usually results in a fast transmission when 
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compared to GPCRs and therefore ligand gated ion channels mediate the fast 
excitatory post synaptic potentials in the enteric nervous system.  
Nicotinic acetylcholine receptors and P2X receptors are ligand gated ion 
channels widely expressed in the GI tract and mediate a variety of functions. In 
the myenteric plexus, they mediate the majority of excitatory neurotransmission. 
Electrophysiological studies using microelectrodes have shown that by using 
nicotinic and P2X antagonists, EPSPs (excitatory post synaptic potentials) are 
blocked in more than 70% of the neurons tested in the myenteric plexus (Nurgali 
et al., 2003). These receptors are co-expressed and are assumed to be present 
on the sensory, motor and interneurons of the ganglia and mediate the enteric 
neurotransmission (Galligan et al., 2004). Moreover these receptors are also 
known to interact with each other allosterically (Zhou et al., 1998).  
ATP and Acetylcholine (ACh), the endogenous ligands at P2X and nAChRs 
respectively are co-transmitters in the ENS (Decker et al., 2009; Zhou et al., 
1998). P2X receptors when activated by ATP allosterically inhibits the ACh 
induced responses at nAChRs. Moreover, the co-expression of P2X receptors in 
HEK cells is associated with an inhibition of nAChR activity. This allosteric 
inhibition is shown to be mediated through the formation of a heteromeric 
complex between P2X and nAChRs (Decker et al., 2010).  
Isolated enteric neuronal culture presents a unique opportunity to study the 
alterations in the activity of neuronal receptors. In the present study, we 
examined the effects of nicotine and ATP, agonists at nAChRs and P2X 
receptors respectively on isolated enteric neurons from LMMP after long term 
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morphine exposure to get a better insight into the mechanism involved in the 
super sensitivity.  
3A. Characterization of enteric neurons in culture: 
The myenteric plexus is a combination of different types of neurons. They can be 
sensory, inter or motor neurons. Based on the type of neurotransmitter released 
they can be inhibitory or excitatory neurons. While acetylcholine contributes to 
the majority of excitatory neurotransmission, VIP and NO contribute to the 
majority of inhibitory neurotransmission (Kunze et al., 1999). Acetylcholine 
releasing (cholinergic) and NO releasing (nitrergic) neurons are localized based 
on the presence of their synthesizing enzymes ChAT (Choline acetyl transferase) 
and NOS1 (Neuronal Nitric oxide synthetase1) respectively. Whereas the VIP 
neurons (vipergic) are localized by immunostaining for the neurotransmitter itself. 
The chemical coding of neurons in the myenteric ganglia has been well 
characterized in the small intestine of guinea pigs and mice (Sang et al., 1996; 
Sang et al., 1998). The goal of the present study was to determine if this 
chemical coding is recapitulated in the isolated enteric neuron culture. In order to 
test that, we compared the chemical coding of neurons in the culture with that of 
the whole tissue myenteric plexus using immunostaining techniques. 
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Results: 
Chemical coding of neurons from the enteric neuronal culture: 
Previous work from our lab has demonstrated the expression of both neurons 
and glia in the isolated cells from the LMMP of ileum (Smith et al., 2013). Figure 
5 shows the expression of neuronal marker β-III tubulin and glial marker GFAP in 
the LMMP and isolated neurons from mouse ileum. In order to localize the 
expression of cholinergic and vipergic neurons in the myenteric ganglia, we used 
transgenic mice expressing a florescent protein tdtomato in cholinergic or 
vipergic neurons. The genetic design of these mice was achieved by inserting the 
sequence for tdtomato in the promotor region of ChAT (a protein expressed 
exclusively in cholinergic neurons) or VIP using a cre-lox recombination 
(Genotype of the animals in the methods section). Tdtomato was expressed in 
the LMMP preparation and isolated enteric neurons from both the transgenic 
mice, suggesting the expression of ChAT and VIP on the cells in the culture (Fig 
6A & B). In order to examine the expression of the nitrergic neurons, we stained 
the myenteric ganglia with the antibody for NOS1 (nitric oxide synthase 1), the 
enzyme responsible for synthesis of nitric oxide in the neurons. The 
immunostaining experiments revealed the expression of nitrergic neurons in 
both, LMMP and isolated neurons (Fig 7A).  
In order to examine the presence of sensory neurons in the isolated culture, we 
studied the immunoreactivity of the calcium binding protein, Calbindin. Previous 
reports have demonstrated the expression of calbindin exclusively in the sensory 
neurons of myenteric plexus (Furness et al., 1988). Immunostaining with the 
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antibody for calbindin showed the expression in both LMMP as well as isolated 
neurons, suggesting the presence of sensory neurons in LMMP and culture (Fig 
7B).  
Similarly, to examine the presence of motor neurons in the isolated culture, we 
studied the immunoreactivity of the calcium binding protein, Calretnin. Calretnin 
was previously shown to be expressed exclusively in the motor neurons of the 
myenteric plexus (Brookes et al., 1991). In the present study we used an 
antibody against calretnin in the LMMP and isolated neurons. Calretinin stained 
positive in the LMMP and isolated culture suggesting the expression of motor 
neurons in the isolated culture (Fig 7C).  
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Figure 6: Chemical coding of enteric neurons - 1: A) ChAT positive and B) 
VIP positive neurons in the LMMP and isolated neurons from the ileum of mice. 
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Figure 7: Chemical coding of enteric neurons – 2. A) NOS1, B) Calbindin and 
C) Calretinin immunopositive neurons in the LMMP and isolated neurons from 
the ileum of mice.  
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Colocalization of the neurotransmitters in the enteric neurons of myenteric 
plexus: 
Previous reports have shown a high colocalization between the VIP and NOS1 
expressing neurons and a low colocalization between NOS1 and ChAT or VIP 
and ChAT in myenteric ganglia of mice (Sang et al., 1996).  In order to compare 
the co-localization of neurotransmitters in LMMP and isolated cells from ChAT 
and VIP mice, we stained them with the antibody targeting NOS1. The 
immunohistochemistry from these experiments revealed the co-localization of 
subpopulation of nitregic neurons with VIP neurons (Fig 8). However there was 
no co-localization seen between cholinergic neurons and the nitrergic neurons 
(Fig 9). The co-localization pattern was similar in the isolated culture suggesting 
that the phenotype of the neurons remained intact after the isolation. 
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Localization of µ-opioid receptors on enteric neurons: 
Opioids effects in the GI tract are mediated through the activation of the µ-opioid 
receptors (MOR) expressed on the enteric neurons. However, the specific 
localization of MORs in the subtypes of neurons is not known. Lack of a specific 
antibody targeting the MOR has been a major limitation in the field in terms of 
studying the localization of these receptors. Several studies have reported the 
non-specificity of the MOR antibodies available in the market (Niwa et al., 2012; 
Smith et al., 2012). However the antibodies used in these studies were raised 
against the c-terminal of the MOR. In the present study we performed 
immunostaining of MOR with the antibody targeting the extracellular 22-38 amino 
acid epitope of N-terminus of the receptor and examined the localization and 
chemical coding of MOR expressing neurons at the whole tissue and isolated 
enteric neuron level. 
Figure 9 shows the expression of MOR in subpopulation of neurons in the 
myenteric ganglia. The antibody also stained positive in the isolated enteric 
neuron culture.  
Co-immunostaining of MOR with NOS1 revealed a low level of colocalization 
observed between the nitrergic neurons and MOR in both whole tissue as well as 
isolated enteric neuron level (Fig 11). 
Colocalization between MOR and ChAT showed a significant co-localization at 
both the whole tissue as well as in the isolated cells suggesting a high level of 
colocalization between these cells (Fig 12).  
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Colocalization was also examined between MOR and VIP. Images from whole 
tissue did not show any colocalization. However, the colocalization in the isolated 
enteric neuron level still needs to be performed (Fig 13). 
These data suggest that the MOR receptors are expressed in isolated enteric 
neurons, primarily in the cholinergic neurons. 
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Figure 10: µ-opioid receptors on enteric neurons. MOR immunopositive 
neurons in the LMMP and isolated neurons from the ileum of mice. 
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Electrophysiological properties of Isolated Enteric neurons: 
Isolated enteric neurons provide a unique opportunity to study the 
electrophysiological properties and alterations in the membrane receptor 
function. Previous reports from our lab have shown that the primary enteric 
neurons isolated from the myenteric plexus are composed of a mixture of 
neurons and glia (Smith et al., 2013; Smith et al., 2014). We used patch-clamp 
technique to study the electrophysiological properties of the neurons in the 
culture. Neurons in the culture were identified based on their ability to elicit action 
potentials in a current-clamp mode. Cells exhibiting action potentials also 
displayed inward currents when depolarized in voltage-clamp mode. Action 
potentials and inward currents were absent in non-neuronal cells which are 
presumably glia (Fig 14). 
Enteric neurons isolated from the transgenic ChAT and VIP mice will help in 
understanding the properties of the cholinergic and VIPergic neurons in the 
culture. ChAT neurons and VIP neurons are identified under the microscope 
based on the expression of florescent protein, tdtomato. Cells expressing 
tdtomato from enteric neuronal culture of ChAT and VIP mice elicit action 
potentials and inward currents similar to neurons from the control swiss webster 
mice suggesting that they are neurons (Fig 15).  
We performed a preliminary study to compare the electrophysiological properties 
of ChAT and VIP neurons. The resting membrane potentials were not 
significantly different among the ChAT +ve and ChAT –ve neurons. The resting 
membrane potential of ChAT +ve and ChAT –ve neurons is -49.4 ± 2.6 mV (n=5) 
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and -46 ± 1.7 mV (n=5) respectively (Fig 16A). However the rheobase, the 
minimum amount of current required for eliciting an action potential were 
significantly higher in ChAT +ve neurons. The rheobase in ChAT +ve and ChAT 
–ve neurons are 23 ± 5.8 and 3 ± 1.2 pA respectively (Fig 16B). This suggests 
that the excitability of cholinergic neurons is lower compared to the other neurons 
in the culture. Only three VIP +ve neurons were tested which didn’t show any 
significant difference with the ChAT +ve neurons in terms of resting membrane 
potential and rheobase. However, the data from VIP -ve neurons, which serve as 
controls, has not been obtained yet.  
Overall, this preliminary study gave us an insight into the distinct 
electrophysiological properties of cholinergic and VIP neurons in the enteric 
nervous system. Future studies examining more biophysical and 
pharmacological properties such as function of ion channels and actions of 
different drugs will help in understanding the role of these neurons in executing 
different functions of the GI tract.  
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Figure 14: Electrophysiology of enteric neurons: A) Current clamp recording 
from a neuron showing an action potential with a current stimulus of 60 pA C) 
Current clamp recording from a glial cell showing no action potential with a 
current stimulus of 100 pA. B) Whole-Cell voltage clamp recordings from neurons 
showing inward sodium current induced upon giving a series of voltage steps 
from -120 mV to 0 mV. D) Whole-cell voltage clamp recording from a glial cell 
without any inward currents. 
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Figure 15: Electrophysiology of cholinergic and vipergic neurons: 
Electrophysiological properties of VIP (n=3) and ChAT (n=5) neurons. 
 
 
47 
 
               
Figure 16: Excitability properties of cholinergic and vipergic neurons: A) 
Resting membrane potentials of neurons from ChAT +ve, ChAT –ve and VIP +ve 
neurons B) Rheobase of ChAT +ve, ChAT –ve and VIP +ve neurons. 
A 
B 
* 
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Summary 3A: 
This study examined the chemical coding and electrophysiological properties of 
isolated enteric neurons in culture. The important findings from this study are as 
follows. 
1) Isolated enteric neurons are a mixture of excitatory and inhibitory neurons 
2) The chemical coding of isolated enteric neurons are representative of the 
neurons at the whole tissue level. 
3) Isolated enteric neurons in culture can be identified based on the action 
potential elicited in patch clamp mode. 
4) µ-opioid receptors are primarily expressed in the cholinergic neurons. 
5) The electrophysiological properties of cholinergic neurons are distinct from 
the non-cholinergic neurons in the culture. 
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3B. Effects of nicotine and ATP on isolated enteric neurons:  
Results: 
Long term exposure to morphine enhances nicotine induced excitability:  
Previous reports have suggested that the enhanced nicotine induced 
contractions in long term morphine treated guinea pigs may be mediated due to 
depolarization of enteric neurons (Kong et al., 1997; Leedham et al., 1992). We 
have previously shown that overnight treatment with morphine (3 µM) results in 
tolerance/dependence which can be functionally examined as enhanced 
excitability upon precipitated withdrawal similar to neurons treated with morphine 
overnight (Smith et al., 2014).  
In the present study we examined the effects of nicotine on resting membrane 
potential, depolarization and excitability properties in the enteric neurons after 
overnight exposure to morphine (16-20 hrs) (3 µM). The resting membrane 
potential and the effects of nicotine were assessed on these cells in a current 
clamp mode. In contrast to the earlier findings, the resting membrane potentials 
were not significantly different in enteric neurons treated with long term 
morphine. The resting membrane potential of enteric neurons from the mouse 
ileum was -47.6 ± 0.6 mV (n=73) and long-term exposure to morphine (16-20 
hrs) (3 µM) did not significantly affect the resting potential -48.3 ± 1 mV; (n=42) 
(Fig 17A). While long-term morphine did not alter the resting potential, the enteric 
neurons were significantly more sensitive to nicotine following morphine 
treatment.  As shown in figure 17B nicotine at 1 µM slightly depolarized control 
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neurons by 2.2 ± 0.3 mV (n=5), however with long-term morphine, the 
depolarization (3.8 ± 1.2 mV (n=8)) resulted in spontaneous action potentials in 
three out of eight cells while action potentials were not generated in cells not 
treated with morphine upon application of 1 µM nicotine. Furthermore, the 
amplitude of depolarization induced by 3 µM nicotine increased significantly in 
morphine treated neurons. At 3 µM nicotine, the depolarization in control cells 
was 9.7 ± 1.2 mV (n=5) and 16.1 ± 2.2 mV (n=8) in long term morphine treated 
cells (Fig 17C). These data suggested that the cells were significantly more 
sensitive to nicotine following long-term morphine treatment.   
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Figure 17: Long term exposure to morphine enhanced the nicotine induced 
excitability: A) Resting membrane potentials of neurons from control (n=73) and 
long term morphine group (n=42) in a current clamp mode. B) Raw traces 
showing the depolarization induced by the 1 µM nicotine in control and after long 
term morphine treatment.C) Amplitude of depolarization induced by 1 µM and 3 
µM concentrations of nicotine in control and long term morphine treated cells. 
Student’s t-test. *P < 0.05 
 
 
52 
 
Long term but not short term exposure to morphine enhances nicotine 
induced currents:  
Enhancement in nicotine induced excitability may be mediated through an 
increase in the nAChR mediated currents. To study the short term and long term 
effects of morphine on nAChRs mediated currents, enteric neurons were treated 
with 3 µM morphine for a period of 10 mins in the bath or over-night for a period 
of 16-20 hours in culture. nAChR activity was assessed on these cells using 
nicotine as an agonist in a whole-cell voltage clamp mode. Cells were held at -60 
mV and the peak amplitude of inward currents were plotted against the nicotine 
concentration (Fig 18).  The dose-response curve displayed an increased nAChR 
activity in cells from prolonged exposure but not in the short exposure group 
when compared to the control drug naïve group. The EC50 values were 44 µM 
(95 % C.I 27 - 61), 39 µM (95 % C.I 25 ± 53) and 42 µM (95 % C.I 28 – 56) in 
control, short-term and after prolonged exposure, respectively (Fig 19A). The 
amplitude of maximal currents induced by a single individual exposure to 1 mM 
nicotine was 139.4 ± 34.3 pA/pF in control and 228 ± 14.7 pA/pF after long-term 
exposure to morphine (Fig 19B). Though there was an increase in the amplitude 
of nicotine induced currents at high concentrations there was no difference seen 
in the EC 50 values among all the three groups suggesting a shift in the efficacy 
but not potency of nicotine post prolonged exposure to morphine.  
In order to further check if these effects of morphine are mediated through the µ-
opioid receptors, we used naloxone, an antagonist at MOR. 1 µM of naloxone 
was added to the cells 30 mins prior to adding morphine and left overnight (16-20 
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hrs) in the culture. Cells treated with 1 µM Naloxone alone overnight were used 
as controls. The currents induced by 1 mM nicotine were not significantly 
changed in the cells treated with naloxone and morphine when compared to the 
controls. This suggested that the effects of morphine are mediated through the 
activation of µ-opioid receptors. 
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Figure 18: Short term but not long term exposure to morphine enhances 
nicotine induced currents - 1: Rawtraces of recording from neurons with 
different concentrations of nicotine in control drug naïve, short term morphine 
treated and long term morphine treated enteric neurons.  
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Figure 19: Short term but not long term exposure to morphine enhanced 
nicotine  induced currents - 2 A) Concentration-response curves of peak 
currents at different concentrations of nicotine. Two-Way ANOVA. Tukey kramer 
Post Hoc test. *P < 0.05 B) Scattered plot showing the distribution of data of 
currents induced by 1mM nicotine from control (n=15), long term morphine 
(n=17), in the presence of 1 µM naloxone (n=5) and Long term morphine in the 
B 
A 
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presence of 1 µM naloxone (n=5). One-Way ANOVA. Tukey kramer Post Hoc 
test. *P < 0.05 
Long term exposure to morphine did not alter ATP induced current:  
The activity of nAChRs is dependent on their interaction with the P2X receptors. 
P2X receptors when activated are known to alter the acetylcholine induced 
currents in the enteric neurons. Decrease in membrane expression of P2X 
receptors increases the nAChR activity and vice versa (Decker et al., 2010; Zhou 
et al., 1998).  
In order to test if the increase in efficacy of nicotine is mediated through the 
change in P2X receptor activity, we examined the effects of long term morphine 
exposure on P2X receptor mediated currents. 1mM ATP, an agonist at P2X 
receptor induced inward current at a holding potential of -60 mV (Fig 20A). ATP 
induced currents were examined in cells exposed to long term morphine. There 
were no significant differences seen among the currents induced by ATP in 
control vs long term morphine treated cells. The amplitude of currents induced by 
1 mM ATP are 73.6 ± 17 pA/pF in control and 56.1 ± 12.4 pA/pF long term 
morphine treated cells (Fig 20B). 
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Figure 20: Long term exposure to morphine did not alter ATP induced 
current: A) Raw trace displaying the inward current induced by 1 mM 
concentration of ATP. B) Amplitude of current induced by 1 mM ATP in control 
(n=7) and long term morphine treated cells (n=5). Student’s t-test. *P < 0.05 
 
A 
B 
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Enhanced responses to nicotine are not associated with dependence in 
enteric neurons:  
Long term exposure to morphine was previously shown to induce tolerance and 
dependence in single enteric neurons from ileum but not in the colon (Ross et al., 
2008; Smith et al., 2014). In order to identify if the enhanced responses to 
nicotine are associated with morphine dependence we studied the effects of long 
term morphine on response to nicotine in enteric neurons from the colon. 
Nicotine induced currents were significantly enhanced at higher doses in cells 
treated with long term morphine. The EC50 values of nicotine were 18.4 µM (95 
% C.I 11.6 – 29.1) in control and 7.1 µM (95 % C.I 3.2 – 15.7) long term 
morphine treated cells respectively (Fig 21A). The amplitudes of currents induced 
by a single exposure to 1 mM nicotine were 148 ± 28.5 pA/pF in control and 222 
± 24.4 pA/pF in long term morphine treated cells respectively (Fig 21B). This 
suggested that the increase in efficacy of nicotine following long term exposure to 
morphine is not associated with or mediated through the morphine dependence. 
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Figure 21: Nicotine induced currents in neurons isolated from mouse 
colon: A) Concentration response curves of nicotine induced currents in neurons 
isolated from mouse colon. B) Scattered plot showing the distribution of data 
peak inward currents induced by 1 mM Nicotine in control (n=6) and long term 
morphine treated cells (n=5). Two-Way ANOVA. Tukey kramer Post Hoc test. *P 
< 0.05 
 
A 
B 
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Summary 3B: 
This study examined the effects of morphine on nAChR and P2X receptor 
activity. The important findings are as follows. 
1) Long term exposure to morphine does not alter the resting membrane 
potential of the isolated enteric neurons. 
2)  Long term but not short term exposure to morphine enhances the nicotine 
induced currents in the enteric neurons. 
3) Long term exposure to morphine does not alter the ATP induced currents 
in the enteric neurons. 
4) Increase in nicotine induced currents is not associated with morphine 
dependence. 
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CHAPTER IV 
Effects of nicotine on opioid-induced constipation in mice 
 
Nicotine, the active ingredient of cigarette smoke alters the GI motility in different 
ways. Short-term application of nicotine through transdermal nicotine patches 
decreases the total colonic transit time (TCTT) suggesting an increase in the 
motility in healthy volunteers. However the reverse is seen after long term 
application (Rausch et al., 1998). The possible explanation is due to the 
desensitization of the receptors. Similarly the total transit time after smoking in 
smokers and non-smokers is significantly high suggesting a decrease in the 
motility (Meier et al., 1995). However, the role of nicotine in these effects is not 
clear as cigarette smoke contains around hundred different constituents. Effects 
of cigarette smoking on GI motility are in contrast to the personal experiences 
reported by smokers that bowel movements are induced by smoking a cigarette 
in the morning.  
Nicotine is an agonist at the nicotinic acetylcholine receptors (nAChRs). 
Activation of the receptor following application of nicotine leads to the 
depolarization of cell membrane. In neurons, this leads to an increase in 
excitability and enhances the release of neurotransmitter.  In a longitudinal 
muscle preparation of small intestinal segment, nicotine induces contractions 
through the activation of the excitatory neurons of myenteric ganglia. In a circular 
muscle preparation, it causes a relaxation through the activation of the inhibitory 
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neurons (Fishlock et al., 1966; Romano, 1981). Additionally, it also increases the 
amplitude of the rhythmic contractions of the intestinal muscle and makes them 
more regular (Alvarez, 1936).  
Although nicotine was proven to have prokinetic effects in the GI tract, it has not 
been used or tested for the treatment of motility disorders. Opioid induced 
constipation is a commonly encountered motility disorder in the clinics. It is 
associated with a decreased contractility and secretion in the intestine. As 
mentioned earlier nicotine at lower doses increases the contractility in the 
intestine and moreover the sensitivity to nicotine is higher in intestines of opioid 
treated animals. Therefore the efficacy of nicotine in inducing motility might be 
higher in the patients who are on opioids. In the present study, we tested the 
effects of nicotine on acute and chronic morphine induced constipation in mice. 
Results: 
Effects of nicotine on small intestinal transit in morphine treated mice: 
Previous reports from our lab have shown that short term and long term 
exposure to morphine significantly decrease the small intestinal transit in mice. 
To determine the effects of nicotine on opioid-induced decrease in motility, small 
intestine transit was measured in mice treated with acute morphine or chronically 
implanted with morphine pellet.  In placebo pelleted mice (control), the distance 
traversed by charcoal gavage was 74.7 ± 7 % of the length of the intestine at 30 
mins post-gavage. A single acute injection (i.p.) of nicotine did not significantly 
affect the transit at 0.175, 0.350 and 0.525 mg/kg, however it significantly 
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decreased the transit at the highest dose (1.05 mg/kg) to 49.3 ± 4 %. A single 
subcutaneous injection of 10 mg/kg morphine in placebo pelleted animals 
significantly decreased the distance for the leading edge of charcoal to 24.9 ± 
2.9 % of the total intestine. Nicotine did not affect the distance traveled at any of 
the doses tested (0.175, 0.350, 0.525 mg/kg) in the acute morphine treated mice. 
In mice pelleted with 75 mg morphine for a period of four days, small intestinal 
transit was 31.5 ± 2.2 % of the total length. There was a significant increase with 
0.525 mg/kg nicotine and a trend towards reversing small intestinal transit at 
lower doses in this group (Fig 22). However, there was no significant increase 
after administration of a higher dose of nicotine 1.050 mg/kg. 
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Figure 22: Effects of 
nicotine on small intestinal 
transit: Scatter plot 
displaying the % distance 
moved by charcoal after a 
single I.P injection of saline 
or different concentrations of 
nicotine in Placebo pelleted 
mice, Placebo pelleted mice 
receiving 10 mg/kg morphine 
and Morphine Pelleted mice 
(N = 5 in each group) One-
Way ANOVA. Fisher’s LSD. 
*P < 0.05 
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Effects of nicotine on whole gastrointestinal transit in morphine treated 
mice: 
Previous reports from our lab have shown that morphine decreases the fecal 
output in mice (Fitting et al., 2015). To examine the effect of nicotine on 
gastrointestinal transit, the total fecal pellets expelled were recorded after 30 
mins administration of nicotine. In placebo-pelleted mice, the number of pellets 
(measured between 30 min – 60 min interval after injection) following saline 
injection was 5 ± 1.1 pellets. A single acute injection (i.p.) of nicotine significantly 
decreased the number of fecal pellets expelled with increasing doses (0.175, 
0.350, 0.525 and 1.050 mg/kg). In mice treated with acute morphine (10 mg/kg), 
there was complete inhibition of pellet expulsion during the first hour and nicotine 
did not stimulate pellet expulsion. However, in morphine pelleted animals, 
nicotine 0.175 mg/kg significantly enhanced the number of fecal pellets expelled 
to 3.3 ± 1. There was however, no significant differences seen with other nicotine 
doses tested (0.350, 0.525 and 1.050) (Fig 23).  These data suggested that 
nicotine can stimulate GI transit within a narrow range of doses in chronically 
morphine-treated mice.  
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Figure 23: Effects of 
nicotine on fecal output 
(30 mins – 60 mins): Scatter 
plot displaying the number of 
fecal pellets expelled after a 
single I.P injection of saline 
or different concentrations of 
nicotine in Placebo pelleted 
mice, Placebo pelleted mice 
receiving 10 mg/kg morphine 
and Morphine Pelleted mice 
(N = 5-10 in each group) 
One-Way ANOVA. Fisher’s 
LSD. *P < 0.05 
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Summary: 
This study examined the effects of nicotine on GI motility in morphine treated 
mice. The important findings are as follows. 
1) Nicotine did not alter the small intestinal motility and fecal pellet output at 
lower doses but significantly decreased the motility at higher doses. 
2) Nicotine reversed the decrease in small intestinal motility and fecal pellet 
output after long term but not short term morphine exposure. 
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CHAPTER V 
THE ROLE OF α3β4 NICOTINIC RECEPTORS IN REVERSING MORPHINE-
INDUCED CONSTIPATION 
 
Previous chapter discussed the role of nicotine in reversing opioid-induced 
constipation. Although nicotine is a stimulatory drug in the GI tract, it only had a 
partial effect in a narrow dose range in reversing chronic opioid-induced 
constipation. This may be attributed largely to the activation of other nAChRs by 
nicotine expressed on other tissues. Therefore identifying and specifically 
targeting the receptor mediating nicotine’s effects in the GI tract may be helpful in 
effectively reversing the opioid-induced constipation. 
As described earlier, nicotine induces contractions in the intestine through the 
activation of nicotinic acetylcholine receptors expressed on the enteric neurons 
(Fishlock et al., 1966). Identifying the subtype of receptors mediating the 
nicotine’s effects on the enteric neurons will help in effectively targeting these 
receptors.   
Nicotinic acetylcholine receptors are pentameric ligand gated ion channels. They 
are either homomeric or heteromeric and are made up of different subtypes of 
subunits. The subunit composition is different all over the body. The 
pharmacological and electrophysiological properties of the different combinations 
of the subunits are unique and therefore help in identification and specifically 
targeting the receptor (Luetje et al., 1991).  
In the nervous system, nicotinic receptors are composed of eleven separate 
subunits α2 – α9 and β2 - β4 subunits (McGehee, 1999; Sargent, 1993). Zhou et 
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al examined the immunohistochemical, pharmacological and electrophysiological 
properties of nAChRs in the enteric neurons isolated from the myenteric plexus 
of neonatal guinea pigs (Zhou et al., 2002). Immunohistochemical studies had 
demonstrated the expression of α3, α5, α7 and β2 subunits in the enteric 
neurons. Similarly, pharmacological studies revealed the functional expression of 
α3, β4 and β2 but not α7 subunits based on the sensitivities to subtype specific 
agonists and antagonists. However the composition of the receptors mediating 
the nicotine or acetylcholine induced responses is not known.  
In the present study, we used genetic and pharmacological approach to identify 
the contribution of each of these subunits and subunit combinations mediating 
the nicotine induced responses in the enteric neurons. We then specifically 
targeted the identified subunit to examine its role in reversing opioid-induced 
constipation and also studied the changes in the expression of subunits after 
chronic morphine exposure. 
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5A. α3β4 subunit is the major nAChR expressed in the mouse enteric 
neurons:  
Results: 
 
mRNA expression of nAChRs in the LMMP of ileum: 
Most of the literature on nAChRs and enteric neurons has been reported from the 
neonatal guinea pigs and nothing is known about the nAChR expression in the 
mouse myenteric plexus. In the present study, we examined the relative 
expression of the subunits by quantifying the mRNA levels of nAChRs in the 
LMMP isolated from the ileum of mice. We first plotted a standard curve with ct 
values obtained with different concentrations of genomic DNA for each primer. 
We then compared the ct values obtained from the sample tissue extracted from 
the LMMP of mouse ileum for each primer in the standard curve. Based on 
where the ct value of sample falls in the standard curve, we calculated the mRNA 
expression of each of the subunits (Fig 24).  Data from qPCR demonstrated the 
expression of nAChRs in the order of α3 > β2 > β4 > α5 > α4 > β3 > α6 subunits 
(Fig 25). These data are in agreement with earlier data from the neonatal guinea 
pig suggesting the expression of α3, β2, β4 and α5 subunits in the enteric 
neurons of myenteric plexus (Zhou et al., 2002). However, these data may not 
reflect the functional expression of these subunits in the neurons.     
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Figure 24: mRNA expression of nAChRs in LMMP -1: Graphs displaying the 
ct values obtained with different concentrations of DNA (●) in the presence of 
different nAChR primers. (▲) indicate the ct values of samples obtained from 
RNA of LMMP tissue obtained from ileum of mice (n=5-6). 
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Figure 25: mRNA expression of nAChRs in LMMP -2: Bar graph displaying 
the gene copy number of samples obtained from RNA of LMMP tissue with 
different nAChR primers. 
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Effects of nicotine on enteric neurons from nAChR knock out mice: 
In order to further examine the functional role of these subunits in the enteric 
neurons, we used a genetic approach. Enteric neurons were isolated from 
nAChR subunit specific knock out mice and the activity of nicotine was 
measured. Enteric neurons isolated from C57BL/6J mice are used as controls as 
they formed the background strain for all nAChR knock-outs.  Figure 26 shows 
nicotine-induced inward currents from α7, α5, α6 and β2 knock out mice. 
Exposure to nicotine (3 uM – 300 uM) induced concentration-dependent inward 
currents in all knock-out mice and were not significantly different in maximal 
amplitude to the C57BL/6J background (Fig 27). This indicates that these 
receptor subunits were not specifically involved in nicotine-induced currents in 
the enteric neurons.  However the nicotine induced currents from α5 knock out 
enteric neurons showed a delayed desensitization compared to the other subtype 
knock out mice suggesting that they may be involved in regulating the 
desensitization of the nAChR expressed in enteric neurons.  
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Figure 26: Nicotine induced currents from nAChR knock out mice - 1: Raw 
traces of currents induced by 0.3 mM nicotine from neurons isolated from LMMP 
of α7, c-57, α5, α6 and β2 K.O mice. 
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Figure 27: Nicotine induced currents from nAChR knock out mice – 2: A) 
Concentration response curves of nicotine induced currents in cells from neurons 
isolated from LMMP of α7, c-57, α5, α6 and β2 K.O mice. Two-Way ANOVA. 
Tukey kramer Post Hoc test. *P < 0.05. Scatter plot displaying the amplitude of 
currents induced by B) 30 µM and C) 100 µM concentrations of nicotine in enteric 
neurons isolated from C-57, β2 K.O, α5 K.O, α6 K.O and α7 K.O mice  
A 
B C 
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Pharmacological properties of nAChRs from isolated enteric neurons: 
As mentioned earlier, the pharmacological properties of different combination of 
the subunits are unique. In order to further define the composition of nAChRs 
mediating nicotine’s effects, we used α3β4 and α3β2/α6β2 nicotinic antagonists 
with different selectivity toward these nAChR subtypes.  Mecamylamine (10 µM) 
and hexamethonium (10 µM) significantly blocked the nicotine induced currents 
at concentrations previously reported to be more preferential for α3β4 receptors 
(Fig 28). This was further confirmed by inhibition of nicotine-induced currents by 
the α-conotoxin, AUIB which has been shown to be highly specific for α3β4 
containing receptor(Harvey et al., 1997; Luo et al., 1998)(Harvey et al., 1997; Luo 
et al., 1998)(Harvey et al., 1997; Luo et al., 1998)(Harvey et al., 1997; Luo et al., 
1998)(Harvey et al., 1997; Luo et al., 1998)(Harvey et al., 1997; Luo et al., 1998) 
(Harvey et al., 1997; Luo et al., 1998). A submaximal dose of AUIB (3 µM) that is 
specific for α3β4 significantly blocked the nicotine induced currents in enteric 
neurons. α-conotoxin M-II (100 nM), a nAChR antagonist specific for α3β2/α6β2 
subtypes did not significantly block the nicotine induced currents in the enteric 
neurons (Harvey et al., 1997) (Fig 29). These findings suggested that the nicotine 
induced currents in the enteric neurons may be primarily mediated through the 
α3β4* nAChR receptors with possible co-expression of α5 subunit modulating 
receptor desensitization. 
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Figure 28: Hexamethonium and mecamylamine block the nicotine induced 
currents in neurons isolated from mouse LMMP: A) Raw traces of nicotine 
induced currents in control cells and in the presence of 10 µM hexamethonium 
(n=5) and 10 µM mecamylamine (n=5) B) Scatter plot showing the distribution of 
the amplitude of current in control and in the presence of 10 µM hexamethonium 
and mecamylamine.  
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Figure 29: α-Conotoxin AUIB but not M-II block the nicotine induced 
currents in neurons isolated from mouse LMMP: A) Raw traces of nicotine 
induced currents in control cells and in the presence of 100 nM M-II and 3 µM 
AUIB. B) Scatter plot showing the distribution of the amplitude of current in 
control and in the presence of 100 nM M-II (n=9) and 3 µM AUIB (n=8)  
 
 
79 
 
Summary 5A: 
 
This study identified the subunit mediating the nicotine induced responses in the 
enteric neurons isolated from the myenteric plexus of mouse ileum. 
1) qPCR studies demonstrated the mRNA expression of nicotinic 
acetylcholine receptors in the order α3 > β2 > β4 > α5 > α4 > β4 > α6 
which are in agreement with earlier studies from neonatal guinea pigs 
2) The amplitude of nicotine induced currents were not significantly different 
in enteric neurons isolated from α5, α6, α7 and β2 knock out mice 
3) The desensitization pattern of enteric neurons from α5 knock out mice 
were delayed compared to controls and other knock outs suggesting its 
involvement in regulating the desensitization 
4) Pharmacological studies using subtype specific antagonists demonstrated 
that the nicotine induced responses in the enteric neurons are mediated 
primarily through the α3β4 subtype of nAChRs 
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5B. Effects of NS3861 on GI motility:  
In chapter three, we demonstrated that the efficacy of nicotine is enhanced in 
enteric neurons after chronic morphine exposure. Similarly, in chapter four, we 
demonstrated that nicotine partially reverses morphine induced constipation in 
chronic but not acute morphine treated animals. In the data presented from the 
earlier section of this chapter, we demonstrated that the nicotine induced 
responses in the enteric neurons were primarily mediated through α3β4 nAChRs. 
Therefore in the present section, we sought to identify the role of α3β4 receptor 
in reversing the morphine induced constipation by using NS3861, a partial 
agonist at the α3β4 nicotinic acetylcholine receptor.  Previous reports from 
heterologously expressed nAChRs in oocytes have demonstrated a higher 
affinity and partial agonist properties for NS3861 at α3β4 subtype of nAChRs. 
However, at relatively higher doses it also displayed full agonist properties at 
α3β2 nAChRs (Harpsoe et al., 2013).  
Results: 
In the present study we examined the effects of different doses of NS3861 in 
reversing opioid-induced constipation by evaluating the gastrointestinal motility. 
In placebo pelleted mice, the number of pellets expelled following a single saline 
injection were 4.25 ± 0.25. NS3861 did not significantly alter the number of fecal 
pellets expelled at 0.01, 0.05, 0.1 mg/kg when given i.p. However, a significant 
decrease was seen at a dose of 0.5 mg/kg. In mice treated with acute morphine 
(a single injection of 10 mg/kg morphine), there was complete inhibition of pellet 
expulsion and NS3861 did not stimulate pellet expulsion. However, in the 
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morphine pelleted mice, where the number of fecal pellets expelled was 
significantly lower at 1.2 ± 0.58, the total fecal pellet expelled increased in a 
dose-related manner with significant increase seen at 0.1 mg/kg NS3861 (5.6 ± 
0.75). This suggested that NS3861 significantly enhanced the motility in opioid-
induced constipation after chronic but not acute administration of morphine (Fig 
30). These effects are lost at a higher dose of NS3861 which may be due to the 
activation of α3β2 receptors expressed on the other tissues. 
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Figure 30: Effects of 
NS3861 on fecal output: 
Scatter plot displaying the 
number of fecal pellets 
expelled after a single I.P 
injection of saline or different 
concentrations of NS3861 in 
Placebo pelleted mice, 
Placebo pelleted mice 
receiving 10 mg/kg morphine 
and Morphine Pelleted mice 
(N = 5 in each group) One-
Way ANOVA. Tukey Kramer 
post-hoc test. *P < 0.05 
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Summary 5B: 
 
This study examined the effects of NS3861 on gastrointestinal motility. The 
important findings are as follows 
1) Single acute administration of NS3861 did not alter the motility in control 
animals at lower doses. However, it significantly decreased the motility at 
a higher dose 
2) Single acute administration of NS3861 reversed the morphine induced 
constipation in a dose-related manner after chronic but not acute exposure 
to morphine. 
3) Effects of NS3861 in opioid induced constipation were not effective at 
higher doses suggesting off-target effects or desensitization of the 
receptors. 
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5C. α3β4 mRNA expression is not altered after prolonged exposure to 
morphine:  
Previous reports in the literature have demonstrated an enhancement in the 
nicotine induced responses in the small intestine of morphine tolerant guinea 
pigs (Goldstein et al., 1973; Johnson et al., 1978). In chapter three, our data 
suggested that the enhanced response to nicotine may be mediated through an 
increase in efficacy of nicotine in the enteric neurons. Similarly, in chapter four, 
we have shown that nicotine partially reversed morphine induced constipation 
after chronic but not acute exposure to morphine. On the same lines, NS3861, a 
α3β4 specific partial agonist also reversed morphine induced constipation after 
chronic but not acute exposure to morphine. This suggested that the enhanced 
activity of nicotinic receptors mediating the nicotine and NS3861 induced motility 
occurs after chronic exposure to morphine. 
In order to test if the enhanced responses to nicotine seen after prolonged 
exposure to morphine are mediated through an increase in transcription of the 
α3β4 nAChR receptor, we examined the mRNA expression of α3 and β4 
subunits in LMMP from mice pelleted with either a placebo or 75 mg morphine for 
four days. The normalized fold changes of mRNA tested using α3 and β4 primers 
show a trend in increase with variable data. However, there was no significant 
increase of both the subunits after chronic exposure to morphine (Fig 31).  
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Figure 31: α3β4 mRNA expression is not altered after prolonged exposure 
to morphine: Normalized fold change of the mRNA of A) β4 and B) α3 subunits 
in placebo pelleted (PP) and morphine pelleted (MP) animals. (N=5) Student’s t-
test *P < 0.05 
 
 
A 
B 
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Summary 5C: 
 
This study examined the changes in the transcription of α3 and β4 genes by 
quantifying the mRNA levels. The normalized fold change of mRNA displayed an 
increasing trend. However, there is no significant change in the mRNA levels 
compared to the controls. This suggests that the enhanced response to nicotine 
after chronic morphine exposure may not be mediated through the increase in 
the transcription of α3 or β4 subtype of nAChRs. 
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CHAPTER VI 
Discussion: 
Overall, the studies described in this dissertation were focused on identifying a 
potential target to reverse opioid-induced constipation. The findings suggest that 
activation of α3β4 subtype of nAChR reverses chronic morphine induced 
constipation. nAChRs are highly expressed on the enteric neurons and an α3β4 
specific partial agonist provides a prokinetic effect following chronic but not acute 
morphine exposure.  
The role of nicotine in reversing morphine induced constipation: 
Previous reports have shown an increase in potency of nicotine induced 
contractions following long term exposure to morphine in the isolated segments 
of guinea pig ileum (Goldstein et al., 1973; Johnson et al., 1978). Nicotine is an 
agonist at the nAChRs and is known to increase motility. We hypothesized that 
nicotine would have an enhanced effect in terms of inducing motility after long 
term exposure to morphine. We tested this hypothesis by examining the effects 
of nicotine on GI motility after short term and long term exposure to morphine. 
Short term (single 10 mg/kg morphine i.p.) and long term (75 mg morphine pellet 
– 4 days) exposure to morphine resulted in reduced small intestinal transit and 
fecal pellet output in mice as previously reported (Fitting et al., 2015; Ross et al., 
2008). Nicotine in a narrow dose-range increased both the small intestinal transit 
as well as fecal pellet output in chronic but not acute morphine treated mice 
(Chapter IV). To test if these enhanced effects are a result of an enhanced 
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activity of nAChRs of enteric neurons we measured nicotine induced currents in 
single neurons (Chapter III). Moreover, the narrow dose range by which nicotine 
enhanced gastrointestinal motility after long term morphine treatment suggested 
that the action of nicotine at the other nAChR subtypes may negate the 
stimulatory effects. Therefore it was important to identify the subtype of nAChR 
mediating the nicotine induced responses. It is also likely that at these higher 
doses, both central actions as well as possible desensitization of the receptors 
prevent nicotine mediated stimulation of peristalsis.  
Long term exposure to morphine enhances nicotine induced currents: 
The enhanced potency of nicotine following long term exposure to morphine in 
the small intestine of guinea pig is attributed to the depolarization of membrane 
potential in enteric neurons (Kong et al., 1997). Microelectrode recordings from 
enteric neurons of myenteric ganglia suggested that the depolarization of enteric 
neurons from chronic morphine treated guinea pigs is mediated through changes 
in the sodium potassium pump activity. However, in the present study, 
membrane potential of isolated single enteric neurons is not altered after long 
term exposure to morphine (16-20 hrs) in culture. We hypothesized that the 
enhanced activity of nAChRs expressed in enteric neurons contributes to the 
enhanced sensitivity to nicotine induced contractions in ileum.  
Previous reports in the literature have used microelectrode recordings from the 
myenteric plexus in an intact tissue preparation to measure the activity of 
neurons (Kong et al., 1997; Leedham et al., 1992; Taylor et al., 1988). Although 
this preparation provides an excellent platform to study the excitability properties 
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of neurons, they may not reflect the activity of receptors as drug induced effects 
might be influenced by the connections from neighboring cells in the tissue. 
Therefore an isolated neuronal cell preparation would be ideal to study the 
activity of receptors expressed on enteric neurons. 
Previous reports from our lab described a technique to isolate neurons from the 
myenteric plexus of mouse ileum (Smith et al., 2012; Smith et al., 2013). Enteric 
neurons in the myenteric plexus are a heterogeneous population of neurons as 
they differ in the functional and neurochemical properties (Brookes et al., 1991; 
Furness et al., 1988; Sang et al., 1998). Although the LMMP tissue contains 
different types of neurons, the composition of the isolated neurons is not known. 
In the present study we examined the chemical coding of the isolated neurons 
using immunostaining techniques. These experiments demonstrated the 
expression of heterogeneous population of the neurons including sensory, motor, 
inhibitory and excitatory neurons in the isolated culture which are representative 
of the neurons from the whole tissue (Chapter III). A very low co-localization has 
been observed between excitatory cholinergic and inhibitory nitrergic neurons 
and high co-localization between inhibitory nitrergic and vipergic neurons which 
was in agreement with previous reports from LMMP of mouse ileum (Sang et al., 
1996; Sang et al., 1998). Moreover, the expression of µ-opioid receptors has 
been primarily localized in the cholinergic and a subpopulation of nitrergic but not 
vipergic neurons. This is in agreement with previous reports suggesting the 
involvement of cholinergic neurons in mediating the effects of opioids in the ileum 
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(Paton, 1957). However, the specificity of the µ-opioid receptor antibody needs to 
be established. 
In order to examine the changes in the nAChR activity following long term 
exposure to morphine, the isolated enteric neurons were treated in culture with 
3µM morphine overnight (16-20 hours). We performed whole-cell patch clamp 
experiments on the isolated enteric neurons and tested the nicotine induced 
responses to assess the activity of the nAChRs. The concentration response 
relation displayed an increase in the efficacy but not potency of nicotine following 
long term but not short exposure to morphine (Chapter III). This suggested that 
the enhanced responses to nicotine in the intestine of morphine tolerant animals 
may be mediated through an increase in nicotine induced currents at the single 
enteric neuron level. Therefore nicotine’s effects on reversing morphine induced 
constipation may be mediated through the activation of these receptors. 
The role of α3β4 nAChR in reversing morphine induced constipation: 
Identifying the subunit composition of nAChRs allows us to specifically target the 
receptor using subtype specific ligands. Data from chapter III and IV suggested 
that targeting the specific subtype of nAChR expressed on the enteric neurons 
may reverse the opioid induced constipation in mice. In the present study we 
approached to identify the subtype of nAChR by examining the mRNA 
expression levels and by using transgenic models along with a pharmacological 
approach in mouse enteric neurons. nAChRs from the LMMP of ileum displayed 
mRNA expression in the order α3 > β2 > β4 > α5 > α4 > β3 > α6 subunits in 
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agreement with previous reports from neonatal guinea pig ileum (Zhou et al., 
2002) (Chapter V).  
Mouse models provide a unique opportunity to study the function of nAChRs by 
using subtype specific knock out mice. The amplitude of nicotine induced 
currents measured from enteric neurons of α7, α6, α5, β2 subunit knock out mice 
were not significantly different from control mice suggesting that they may not be 
the subunits mediating nicotine induced currents in the enteric neurons. 
However, nicotine induced currents from α5 knock out mice displayed a delayed 
desensitization pattern suggesting that α5 may also be a potential subunit 
modifying the inactivation of the nicotine induced currents (Chapter V).  The 
current profile of α5 knock-out enteric neurons is similar to that seen by 
Gerzanich et al in α3 expressing oocytes  (Gerzanich et al., 1998). While further 
studies are needed to examine in the α3 and β4 knock out mice, the main 
limitation is that α3 null mutant mice do not survive to adult hood (Xu et al., 
1999).  
In order to further examine if the subunit composition is mediated through the α3 
subtype of nAChR we used a pharmacological approach. Hexamethonium (10 
µM), a non-selective antagonist significantly decreased the nicotine induced 
currents. Mecamylamine (10 µM), a nicotinic antagonist, completely abolished 
the nicotine induced currents at a concentration highly specific for α3β4 (Papke 
et al., 2010). Similarly, α-Conotoxin AUIB (3 µM) at a concentration highly 
specific for α3β4 also significantly reduced nicotine induced currents (Harvey et 
al., 1997; Luo et al., 1998; Zhou et al., 2002). However, α-Conotoxin M II (100 
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nM) at a concentration highly specific for α3β2 did not change the nicotine 
induced currents (Chapter V).  Collectively, these data suggested that α3 and β4 
subunits mediate the nicotine induced currents in enteric neurons. α5 subunit 
may be co-expressed with this nicotinic subtype and modulate its desensitization 
properties. Although there was a high mRNA expression of β2 subunit in the 
LMMP of mouse ileum, there seems to be no functional role played by this 
subtype of nAChR in the enteric neurons.  
Since it was determined that the α3β4 subtype of nAChR mediates nicotine 
induced currents in enteric neurons, we next tested if the activation of these 
receptors can reverse opioid-induced constipation (Harpsoe et al., 2013). α3β4 
subtype of nAChRs are expressed in different parts of the body including the 
brain. They are ganglionic receptors and mediate different funcions of the 
sympathetic nervous system. Activation of these receptors using α3β4 specific 
agonist may overexcite them and alter the functions of sympathetic nervous 
system. Therefore, using a partial agonist is a better strategy in activating these 
receptors as they avoid over excitation of the receptors. Partial agonists can act 
as functional agonists in the absence of endogenous agonist and as antagonists 
in the presence of excess agonist. Since morphine is known to decrease the 
release of endogenous neutransmitter acetylcholine by the enteric neruons, 
partial agonist can act as functional agonists to activate these neurons.  
In the present study we tested the effects of NS3861, an α3β4 specific partial 
agonist on GI motility. Fecal pellet output assay performed using NS3861 
displayed an enhancement in the number of fecal pellets expelled in long term 
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but not short term morphine treated mice (Chapter V). This suggests that the 
α3β4 subtype of nAChR provides a potential target to reverse chronic morphine 
induced constipation. However, the effects of NS3861 were lost at higher doses. 
This may be attributed to the actions of NS3861 at α3β4 or α3β2 receptors in the 
brain. 
Although both the nicotine and NS3861 reversed constipation after chronic 
morphine treatment, it is not clear if these effects are mediated through the 
activation or the desensitization of the receptor. Blocking the effects of nicotine 
and NS3861 using α3β4 specific antagonists such as mecamylamine would help 
in identifying such mechanisms. 
Mechanism of action: 
Previous reports in the literature and the results from the present studies have 
demonstrated an enhancement in the nAChR activity following long term 
exposure to morphine both in vivo and in vitro. However, the mechanism involved 
in this enhancement is not understood.  
Long term exposure to morphine is associated with changes in the intracellular 
environment of the enteric neurons which further leads to dependence (Gintzler 
et al., 2006). Naloxone, an antagonist at µ-opioid receptor enhances the 
excitability of isolated enteric neurons from ileum of mice after overnight 
exposure to 3 µM morphine suggesting the induction of precipitated withdrawal or 
morphine dependence. However, naloxone was ineffective after overnight 
exposure to morphine in enteric neurons isolated from colon, suggesting that 
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dependence is absent in these cells (Smith et al., 2014). In order to test if the 
morphine’s effects on nicotine induced currents are associated with dependence, 
we tested the effects of long term morphine in neurons isolated from colon. 
Concentration response relation with nicotine showed an increase in nicotine 
induced currents with an increase in efficacy but not potency (Chapter III). This 
suggested that the enhanced nAChR activity may not be associated with 
morphine dependence. 
ATP and acetylcholine, endogenous agonists at the P2X and nAChRs are co-
transmitters and contribute to the majority of neurotransmission in the GI tract 
(Zhou et al., 1998). Moreover, the activity of nAChRs is regulated by P2X 
receptors as they are known to be expressed in closed proximity and form 
heteromers (Decker et al., 2009; Decker et al., 2010). However, in the present 
study, ATP induced currents were not significantly changed after long term 
exposure to morphine (Chapter III). This suggested that the effects of morphine 
are specific for nAChRs and P2X receptors are not involved in increased efficacy 
of nicotine.  
An increase in the nicotine induced currents may be due to an increase in the 
receptor number or a post translational modification leading to changes in 
biophysical properties of the receptor. Increase in the receptor number can be 
mediated through an increase in the transcription of the receptor gene or 
alteration in membrane trafficking of the receptor. However, the experiments 
done in the present study showed no significant differences in the mRNA levels 
of α3 and β4 subtype of nAChRs in the LMMP of placebo and morphine pelleted 
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mice (Chapter III). Previous reports have shown that by phosphorylating or 
altering membrane trafficking, nAChR activity can be enhanced (Govind et al., 
2009; Walsh et al., 2008; Wecker et al., 2010). Increased nAChR numbers is 
also reported in brains of morphine dependent mice (Neugebauer et al., 2013). 
Further studies will be required to examine protein expression levels of nAChR 
after chronic morphine in enteric neurons. 
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Figure 32: Model displaying the changes in the activity of µ-opioid receptors and 
nAChRs after actute and chronic exposure to morphine in enteric neurons of 
ileum and colon. 
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Limitations: 
Just like any other study, the experiments described in this dissertation also have 
limitations. Specific limitations from each chapter are listed below. 
Chapter III: 
Immunostaining using µ-opioid receptor antibody: There is a lot of debate in 
the literature over the specificity of antibodies used against µ-opioid receptors 
(Niwa et al., 2012; Smith et al., 2012). The data from the present study 
suggested the presence of µ-opioid receptors on cholinergic and nitrergic 
neurons. This was in agreement with previous reports where it was demonstrated 
that morphine acts by inhibiting the release of acetylcholine at neuromuscular 
junction of longitudinal muscle in the small intestine (Paton, 1957). However, the 
specificity of this antibody is yet to be determined using µ-opioid receptor knock 
out mice. 
Direct effects of morphine on nAChRs: Although the effects of morphine in the 
present study were shown to be mediated thorugh the mu-opioid receptors, there 
is also a possibility of these receptors binding directly to the nAChRs. Previous 
reports have demonstrated the binding of morphine to different subtypes of 
nAhRs at higher concentrations (Talka et al., 2013). The involvement of direct 
binding of morphine to nAChRs in the enteric neurons can be tested using mu-
opioid receptor knock-out animals. 
Concentration response to nicotine: Nicotine is an agonist at nAChR and is 
known to rapidly desensitize the receptor. Multiple exposures to nicotine are 
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known to irreversibly desensitize the receptor resulting in reduced currents (Zhou 
et al., 2002). Concentration response experiments in the present study with 
nicotine involved multiple exposures. In order to confirm that the results from 
concentration responses are showing an increase in efficacy, we also performed 
a separate experiment where we treated our cells with a single exposure to 1 mM 
nicotine. In both the cases, an increase in nicotine induced currents was seen 
after long term exposure to morphine.  
Previous studies have used specialized systems controlled by a picospritzer 
(General valve) to deliver nicotine directly to the vicinity of the cell in the bath 
solution (Zhou et al., 2002). These systems control the delivery of drug through a 
pressure pulse and avoid over exposure of nicotine to the cells. This helps in 
preventing desensitization of the receptors. However, in the present study we 
perfused the drug directly into the whole bath solution using a gravity flow. 
Although the receptors are more prone to desensitization in this procedure, it is 
more representative of a physiological exposure.  
Analysis of nicotine induced currents: Exposure to higher concentrations of 
nicotine produced rebound currents apart from the peak currents inducating the 
rapid recovery of channels from the blocked state. Plotting the total change in 
charge after exposure to nicotine will include the responses of peak currents and 
rebound currents. However in the present study nicotine induced currents were 
assayed by plotting only the peak currents of the raw traces as the rebound 
currents were found to be proportional to the peak currents. 
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Morphine concentration: Previous reports from our lab demonstrated that acute 
exposure to 3 µM morphine decreases the excitability of neurons and long term 
exposure leads to tolerance and dependence in the single enteric neurons. 
Although 3 µM concentration of morphine is considered high, it is still 
representative of the concentration of the morphine in vivo in mice, as surgical 
implantation of a morphine pellet is associated with an increase in serum 
morphine concentration to 4 µM on the day of surgery which progressively 
decreases to a concentration of 2 µM on day 5 after the surgery (Zhang et al., 
2011). 
Effects of morphine on enteric neurons were examined by exposing the cells to 
morphine in culture. However, it is also important to study the effects of morphine 
exposure in vivo. The drawback of performing such an experiment is that the 
neurons isolated from animals should be allowed to settle down overnight in 
culture before performing any functional studies. Isolated cells might lose the 
phenotype acquired after morphine treatment in vivo during the overnight settling 
period. Therefore, an alternate method that can allow us to use the cells 
immediately after isolation would help to study the effects of morphine exposure 
in vivo. 
Chapter IV: 
Fecal pellet output assay: Previous reports from our lab have shown that 
morphine dose-dependently decreases the fecal pellet output in mice (Fitting et 
al., 2015). The main drawback with this experiment is that the amount of food 
consumed by the mice is not controlled. This may be the reason for higher 
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variability seen in the data. In spite of this drawback, mice still showed a dose-
dependent decrease in the fecal pellet output after administration of morphine 
suggesting the credibility of this assay (Fitting et al., 2015). However, controlling 
the amount of food consumed by the animals might increase the sensitivity of this 
assay and decrease the variability. 
Chapter V:  
Knock out models: nAChR subunit specific knock out mice were used to 
identify the subunit mediating nicotine induced currents in enteric neurons. The 
drawback with this experiment was that, C57BL/6J mice and not wild type 
littermates were used as controls. However, nicotine induced currents in the 
knock out models were not significantly different among each other and when 
compared to C57BL/6J mice. We believe that this information is enough to 
suggest that the nicotinic receptor subtypes tested here are not the candidate 
subunits mediating nicotine induced currents in the enteric neurons. 
Experiments with antagonists: In order to evaluate the subtype of nAChR 
expressed on the enteric neurons, we used subtype specific antagonists to block 
nicotine induced currents. However, only a single effective concentration of 
antagonists was tested instead of a concentration response to avoid multiple 
exposures to nicotine. 
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Future Studies: 
Peripherally selective α3β4 partial agonist: α3β4 subtype of nAChRs are 
expressed in both the central and peripheral tissues. Activation of the receptors 
in the brain may negate the stimulatory effects in the periphery. Therefore, 
development of peripherally selective α3β4 partial agonists may be of therapeutic 
benefit in treatment of chronic opioid-induced constipation. 
Effects on propulsive motility: Although nicotine and NS3861 enhanced the 
fecal pellet output in mice after long term morphine exposure, their actions on the 
propulsive motility is not known. Gastrointestinal motility monitor (GIMM) is an 
excellent devise designed to study the propulsive motility in isolated segments of 
intestine. Effects of nicotine and NS3861 can be evaluated on isolated ileal and 
colon segments using this devise. 
Mechanism of action: Long term exposure to morphine is associated with 
alterations in the activity of kinases such as PKC and PKA (Dalton et al., 2005; 
Narita et al., 1994). Moreover, post-translational modifications of nAChRs such 
as phosphorylation mediated through PKC were shown to enhance the activity of 
receptor (Wecker et al., 2010). Therefore, examining the changes in the level of 
phosphorylation or changes in the activity of kinases such as PKC or PKA may 
help in understanding the mechanism of action involved in changes seen after 
long term exposure to morphine. 
Role of cholinergic and vipergic neurons in morphine’s effects: 
Electrophysiological properties of cholinergic and vipergic neurons from the 
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myenteric plexus can be examined using transgenic mouse models as described 
in the chapter III. Identifying these properties will allow us to understand the 
physiological and drug induced effects mediated through the cholinergic and 
vipergic neurons in the GI tract. Moreover, immunostaining experiments also 
revealed the expression of µ-opioid receptors in cholinergic and nitrergic but not 
vipergic neurons. These findings can be further confirmed by testing the effects 
of short term and long term exposure to morphine on cholinergic and vipergic 
neurons. These experiments will help us in understanding the subtype of enteric 
neurons involved in mediating the morphine’s effects in the GI tract. 
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